SCHEMBL20718445

SCHEMBL20718445

COC(=O)c1ccc(-c2ccc(C=O)o2)o1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.63
KDM4E B2RXH2 6/20 0.63
HTT P42858 2/20 0.51
NPC1 O15118 2/20 0.50
MAPT P10636 2/20 0.50
RAB9A P51151 2/20 0.50
SETD7 Q8WTS6 1/20 0.50
HSP90AA1 P07900 1/20 0.50
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
STAT1 P42224 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
POLB P06746 5/20 0.46
HPGD P15428 2/20 0.46
TP53 P04637 1/20 0.46
CHRM2 P08172 1/20 0.46
CHRM4 P08173 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2324097 0.93 HTT (0.55) ALDH1A1KDM4EHTTNPC1MAPT
SCHEMBL28577903 0.91 HTT (0.53) ALDH1A1KDM4EHTTNPC1MAPT
SCHEMBL21981938 0.84 HTT (0.67) ALDH1A1KDM4EHTTNPC1MAPT
SCHEMBL18914368 0.82 HTT (0.49) ALDH1A1KDM4EHTTNPC1MAPT
SCHEMBL29952713 0.81 KDM4E (0.59) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL4399339 0.80 KDM4E (0.72) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL18914742 0.80 HTT (0.46) ALDH1A1KDM4EHTTNPC1MAPT
SCHEMBL26078289 0.79 SMN1; SMN2 (0.58) ALDH1A1HTTNPC1MAPTRAB9A
SCHEMBL69791 0.78 HTT (0.69) ALDH1A1KDM4EHTTNPC1MAPT
SCHEMBL6656195 0.78 ALDH1A1 (0.61) ALDH1A1KDM4EHTTNPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200369659-A1 SELECTIVE LIGANDS FOR TAU AGGREGATES CBD SOLUTIONS AB (SE) 2020-11-26 US disclosed
WO-2019025595-A1 SELECTIVE LIGANDS FOR TAU AGGREGATES KARIN & STEN MORTSTEDT CBD SOLUTIONS AB (SE) 2019-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369659-A1 SELECTIVE LIGANDS FOR TAU AGGREGATES MAPT, PSEN1, PSEN2 ALDH1A1 3634/4885KDM4E 4702/4885HTT 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.